E-ERAD-107 - RNA-seq of human IPS cells to investigate genetic and epigenetic variation. EGA study.

Status
Released on 11 July 2013, last updated on 1 May 2014
Organism
Homo sapiens
Samples (47)
Protocols (2)
Description
In order to progress human induced pluripotent stem cells (hiPSCs) towards the clinic, several outstanding questions must be addressed. It is possible to reprogram different somatic cell types into hiPSCs and from studies in the mouse, it appears that an epigenetic memory of the starting cell type is carried over to hiPSCs. However a comprehensive comparative study of the characteristics of these hiPSCs has been missing from the literature. Importantly studies which aimed to address these aspects of hiPSCs have used cells from different patients. In order to avoid this important confounding variable and to keep the genetic background constant, tissue samples were procured from the patients and reprogrammed to iPS cells. The transcriptomes of these iPS cells will be compared. Protocol: primary cultures of cells were reprogrammed to iPS cells. RNA was extracted using a standard column extraction kit.
Experiment types
RNA-seq of coding RNA, cell type comparison design
Contact
MINSEQE
Exp. designProtocolsFactorsProcessedSeq. reads
Files
Investigation descriptionE-ERAD-107.idf.txt
Sample and data relationshipE-ERAD-107.sdrf.txt
Links